3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
12
Spondylitis, Ankylosing
4
Psoriasis
2
Inflammatory Bowel Diseases
2
Thyroid Carcinoma, Anaplastic
1
Spondylarthritis
1
Sarcoidosis
1
Osteoarthritis
1
Nephrotic Syndrome
1
Nephrosis, Lipoid
1
Mucopolysaccharidosis VI
1
Mucopolysaccharidosis II
1
Mucopolysaccharidosis I
1
Mucopolysaccharidoses
1
Macular dystrophy, corneal type 1
1
Kidney Diseases
1
Joint Diseases
1
Inflammation
1
Infections
1
Glomerulosclerosis, Focal Segmental
1
Dupuytren Contracture
1
Crohn Disease
1
Colitis, Ulcerative
1
Autoimmune Diseases
1
Arthritis, Psoriatic
1
Arthritis
1
Interventions
Microbial Collagenase
9
xiapex
5
Surgical Procedures, Operative
2
Sodium Chloride
2
Collagenases
2
Triamcinolone Acetonide
1
Transplantation
1
Tranexamic Acid
1
Therapeutics
1
Surveys and Questionnaires
1
Restraint, Physical
1
Radiotherapy
1
Oxycodone
1
Injections, Intra-Articular
1
Ibuprofen
1
High-Energy Shock Waves
1
Fasciotomy
1
Extracorporeal Shockwave Therapy
1
Enzymes
1
Dexamethasone
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Knee
1
Arthroplasty, Replacement, Elbow
1
Adrenal Cortex Hormones
1
Adalimumab
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Dupuytren Contracture
×
Adalimumab
×
Clear all
NCT03180957
2024-06-28
RIDD
University of Oxford
Phase 2
Completed
140 enrolled
29 charts